baber/WOPTO huggingface dataset:
Patent JP-3178874-B2 (JP)
IPC: H01L21/607
Filed: 1991-12-24
Granted: 2001-06-25
Abstract: A process and a device for carrying out the process for the ultrasonically bonding wire connection of electrical circuits on metal system carriers are proposed. 
<??>The device (100) essentially comprises a bonding-head means (50) with an energy transducer (50) arranged on it. The energy transducer (50) is fed into the respective process point (P) of the system carrier (46) and a first voltage is applied to it to produce a longitudinal oscillation amplitude. A measuring head (55) arranged in a fixed position on a machine base (60) is allocated to the bonding-head means (50). 
<??>The measuring head (55) has an optical/electrical sensor (52) by means of which the instantaneous amplitude of the longitudinal oscillation as well as the extent of the infeed movement of the bonding-head device (50) are measured, and a correction factor is determined by calculation from the measured variables determined and is calibrated with the correction factor of the first ultrasonic value for the oscillation amplitude of the energy transducer (25). 
<IMAGE>
Patent JP-4067123-B2 (JP)
IPC: A61K47/48
Filed: 1997-06-04
Granted: 2008-03-26
Abstract: The present invention relates particularly to neoplastic cells targeted chimeric toxins comprising of cell targeting moieties and cell killing moieties for recognizing and for destroying the neoplastic cells, wherein the cell targeting moieties consist of gonadotropin releasing hormone homologues and the cell killing moieties consist of Pseudomonas Exotoxin A. The present invention further relates to pharmaceutical compositions containing as an active ingredient these neoplastic cells targeted chimeric toxins and to a method for the production of these chimeric toxins. The said invention also relates to a method for cancer therapy, treating malignant carcinoma cells and benign hyperplasia including uterine leiomyoma cells, extrauterine endometrial island cells, benign hyperplasia of prostate and breast and pituitary tumor adenoma cells, by the use of the above-mentioned chimeric toxins.
Patent JP-3313710-B2 (JP)
IPC: A61K31/785
Filed: 1992-06-23
Granted: 2002-08-12
Abstract: Pharmaceutical tablet comprises (a) one or more excipients, and (b) an amt. of Colestipol hydrochloride (I) effective for treating or preventing hypercholesterolemia in a patient to whom one or more tablets are administered, and has the following physical characteristics: hardness 40-75 SCUs; thickness 0.200-0.340 inch; and friability 0-0.1%/15 mins.. (I) is finely milled and the tablet has the following additional characteristics: tablet wt. 1017-1079 mg. and disintegration time of less than 5 mins. The excipients are povidone, colloidal silicon dioxide and magnesium stearate. Pref. the tablet has 1000 mg. of (I). The tablet wt. is 1048 mg., the hardness is 40-50 SCUs, and the thickness is 0.320-0.340 inch.
Patent JP-4223554-B2 (JP)
IPC: G01P15/18
Filed: 1997-06-19
Granted: 2009-02-12
Abstract: The invention relates to a sensor device for measuring attitude, acceleration or gravitational field and its gradient components. The device includes a spherical cavity (3) which contains a sensor substance in the form of a fluid or some other inertial material having fluidic properties. The cavity (3) is provided with measuring sensors or measuring electrodes (-x, +x; -y, +y; -z, +z) for three different coordinate axes x, y, z, all of said sensors responding to said common inertial mass which fills the cavity (3). Such assembled single compact measuring device can be used for determining any of the said quantities 3-dimensionally.
Patent JP-3333506-B2 (JP)
IPC: C07K19/00
Filed: 1991-02-08
Granted: 2002-10-15
Abstract: Methods are disclosed for producing hybrid G protein-coupled receptors. DNA sequences encoding hybrid G protein-coupled receptors are provided, wherein the receptors comprise mammalian G protein-coupled receptors having at least one domain other than the ligand-binding domain replaced with a corresponding domain of a yeast G protein-coupled receptor. DNA constructs comprising the following operatively linked elements: a transcriptional promoter, a DNA sequence encoding a hybrid G protein-coupled receptor, wherein the receptor comprises a mammalian G protein-coupled receptor having at least one domain other than the ligand-binding domain replaced with a corresponding domain of a yeast G protein-coupled receptor, and a transcriptional terminator. Host cells transformed with the DNA constructs and methods utilizing the transformed cells are also provided.
Patent JP-3006881-B2 (JP)
IPC: A61K31/40
Filed: 1991-03-28
Granted: 2000-02-07
Abstract: The present invention is directed to a new class of 3-indolyl thioacetate derivatives which the NMDA antagonists.
Patent JP-3447731-B2 (JP)
IPC: C07K14/81
Filed: 1992-02-28
Granted: 2003-09-16
Abstract: The present invention relates to libraries of display phage which display various mutant epitopic peptides or protein domains with potential to bind to a target material of interest. Site-specific protease cleavable linkers may be incorporated into these phages to overcome the problem of irreversible binding to target materials. When the displayed insert is a mini-protein, a reagent which cleaves the crosslink may be used to facilitate release of a tightly bound display phage. The invention also relates to providing a more balanced library of epitopic peptide display phage.
Patent JP-3507486-B2 (JP)
IPC: A61P31/04
Filed: 1992-03-13
Granted: 2004-03-15
Abstract: Granulocyte-colony stimulating factor (G-CSF) can be delivered systemically in therapeutically or prophylactically effective amounts by pulmonary administration using a variety of pulmonary delivery devices, including nebulizers, metered dose inhalers and powder inhalers. Aerosol administration in accordance with this invention results in significant elevation of the neutrophil levels that compares favorably with delivery by subcutaneous injection. G-CSF can be administered in this manner to medically treat neutropenia, as well as to combat or prevent infections.
Patent JP-3108095-B2 (JP)
IPC: A61P31/12
Filed: 1991-07-30
Granted: 2000-11-13
Abstract: Peptides useful for protecting humans from Human Respiratory Syncytial Virus infection is disclosed. Vaccines comprising the peptides and a method of protecting humans from HRSV infection are disclosed.
Patent JP-3398900-B2 (JP)
IPC: B09B3/00
Filed: 1995-09-26
Granted: 2003-04-21
Abstract: A fluid change system (10) for use in changing fluid, i.e. motor oil from machinery has a portable "suitcase" unit (12) and a recharge unit (14) for recharging the suitcase unit. The suitcase unit has a used fluid tank (22), a new fluid tank (20), and a compressed air tank (18) and a four way control valve (56). Recharge ports (58, 60, 62, 64, 66) allow for recharge of the suitcase unit through which the new fluid tank is refilled with new fluid and recharged with pressurized inert gas, the used fluid tank is emptied and placed under vacuum, and the compressed air tank is refilled with compressed air. A venturi (84) allows extra vacuum to be placed on the used fluid tank by a user. A computer (212) controls the recharge sequence.
Patent JP-3180106-B2 (JP)
IPC: A61K47/48
Filed: 1991-10-23
Granted: 2001-06-25
Abstract: A homopolymer of a (meth)acrylic acid derivative represented by general formula (I), a process for producing the same by mechanochemical polymerization, and polymer drug and prodrug containing the same: wherein R<1> represents hydrogen or methyl; R<2> represents a residue of a compound having a physiological activity in its chemical structure; X represents a residue of a compound having hydroxyl, amino or carboxyl groups at both terminals in its chemical structure; and n is such a number as to give a number-average molecular weight of 20,000 to 200,000. <CHEM>
Patent JP-3457316-B2 (JP)
IPC: H04W88/18
Filed: 1994-02-23
Granted: 2003-10-14
Abstract: The invention relates to a method of managing transmission errors between a base station and a transcoder, in a digital radiocommunications system for mobile stations, in which method the transcoder, in the presence of a transmission error, systematically inserts (29, 221, 228) an error message in a frame addressed to the base station without interrupting useful data transmission to the base station, and in which method the base station decides to interrupt data transmission to the transcoder (down direction) and generates an up-direction transmission interruption request when the transmission errors detected in the down direction and/or reported by an error message in the up direction satisfy predetermined conditions. In this way, all call-interruption decisions are centralized in the base station.
Patent JP-4283894-B2 (JP)
IPC: C07C213/10
Filed: 1997-10-16
Granted: 2009-06-24
Abstract: PCT No. PCT/HU97/00064 Sec. 371 Date Jun. 14, 1999 Sec. 102(e) Date Jun. 14, 1999 PCT Filed Oct. 16, 1997 PCT Pub. No. WO98/17230 PCT Pub. Date Apr. 30, 1998The new compound of Formula (I) and salts thereof possess valuable anxiolytic properties.
Patent JP-3539973-B2 (JP)
IPC: C08L51/00
Filed: 1995-12-20
Granted: 2004-07-07
Abstract: PCT No. PCT/EP95/05056 Sec. 371 Date Jun. 16, 1997 Sec. 102(e) Date Jun. 16, 1997 PCT Filed Dec. 20, 1995 PCT Pub. No. WO96/19509 PCT Pub. Date Jun. 27, 1996Emulsion graft copolymers are composed of A) from 5 to 18% by weight of a first stage comprising a1) from 85 to 99% by weight of methyl methacrylate, a2) from 1 to 15% by weight of C1-C8-alkyl acrylate, a3) from 0 to 2% by weight of allyl methacrylate and a4) from 0 to 3% by weight of further di- or polyfunctional comonomers, B) from 25 to 35% by weight of a second stage comprising b1) from 10 to 25% by weight of vinylaromatic monomers, b2) from 75 to 90% by weight of C1-C20-alkyl acrylate and b3) from 0 to 3% by weight of allyl methacrylate, C) from 30 to 40% by weight of a third stage comprising c1) from 15 to 27% by weight of vinylaromatic monomers, c2) from 73 to 85% by weight of C1-C20-alkyl acrylate and c3) from 0 to 3% by weight of allyl methacrylate and D) from 15 to 30% by weight of a fourth stage comprising d1) from 85 to 96% by weight of methyl methacrylate, d2) from 3.8 to 10% by weight of C1-C8-alkyl acrylate, d3) from 0 to 2% by weight of further di- or polyfunctional comonomers and d4) from 0.2 to 3% by weight of a regulator, with the proviso that the ratio of the amounts of vinylaromatic monomers c1:b1 is from 1.3:1 to 1.9:1 and the sum of the components A to D is 100% by weight.
Patent JP-3789137-B2 (JP)
IPC: G03F7/027
Filed: 1996-11-27
Granted: 2006-06-21
Abstract: The invention relates to photosensitive compositions capable of being developed as positives. Conventional compositions are either insufficiently photosensitive or unsuitable for use on copper surfaces such as those in printed circuit boards, since the exposed regions of the composition layer cannot be completely removed during development and create problems in the subsequent metal-coating or etching operations. These drawbacks are not found with the claimed photosensitive compositions. Various compositions are described containing photo-acid generators and a polymer resin containing acid-cleavable side groups and formed by polymerisation of at least three different acrylate or methacrylate monomers.
Patent JP-3862752-B2 (JP)
IPC: C07K16/18
Filed: 1996-03-27
Granted: 2006-12-27
Abstract: Synthetic peptides based on a complementarity-determining region (CDR) of the heavy or light chain of a pathogenic anti-DNA monoclonal antibody that induces a systemic lupus erythematosus (SLE)-like disease in mice, and analogs, and salts and chemical derivatives thereof; dual peptides comprising two such peptides or analogs covalently linked to one another either directly or through a short linking chain; peptide polymers comprising a plurality of sequences of said peptide or analog thereof; and peptide polymers attached to a macromolecular carrier, are disclosed, and pharmaceutical compositions comprising them for the treatment of SLE in humans.
Patent JP-4283892-B2 (JP)
IPC: A61K31/58
Filed: 1997-04-29
Granted: 2009-06-24
Abstract: A biologically active stick composition comprising a biologically active agent dissolved in a carrier system including an unsaturated fatty acid alcohol in mutual dissolution with an alkylene glycol as a solvent for said biologically active agent and a stiffening agent therefor, said stiffening agent imparting stick consistency to the composition, said alkylene glycol preferably being present in an amount of more than 12%. The composition can be prepared by dissolving the active agent in the solvent, combining the solution with the stiffening agent and shaping the formulation into a stick. The composition is especially intended for use as a medicament, preferably in the treatment of dermatological conditions, where it has been found to possess outstanding bioavailability properties.
Patent JP-4226081-B2 (JP)
IPC: H04W4/12
Filed: 1998-04-01
Granted: 2009-02-18
Abstract: The invention relates to delivery of short messages to mobile stations and particularly to delivery of short messages in mobility-supporting packet radio networks that use a mobile communications network as an access network, to a dual-mode mobile station in a situation where the mobile station is not reachable in the packet radio network. The object of the invention is to minimize unnecessary signalling. The invention is based on the fact that parameters controlling the network elements are inserted into the signalling messages and a flag indicating the state of the mobile station is inserted into the home location register. The method and radio network of the invention, the signalling messages may contain parameters by means of which 1) delivery of a short message through the secondary network is prevented, 2) information on the fact that an attempt was made to reach the mobile station but the attempt was not successful is sent to the node of the secondary network, 3) the node of the secondary network is prevented from informing the home location register of the mobile station of the attach of the mobile station to the network, 4) information is sent to the home location register on the fact that the mobile station cannot be reached through the primary network, and 5) information is sent to the gateway mobile switching center for short message service on the fact that the mobile station can be reached through the primary network even though the short message was delivered through the secondary network.
Patent ES-2235588-B2 (ES)
Title: Mejoras introducidas en la patente principal n. p200201991 relativa a un precinto de seguridad para tapon.
Inventor: TORRENT ORTEGA DAVID
IPC: B65D41/32
Filed: 2003-01-10
Granted: 2005-12-16
Abstract: Mejoras introducidas en la patente principal nº P200201991 relativa a un precinto de seguridad para tapón. La presente invención se refiere a mejoras introducidas en la patente principal nº P200201991 relativa a un precinto de seguridad para tapón consistentes en establecer un adecuado modo de fijación entre el precinto de seguridad y el cuerpo interno o tapón sobre el que se acopla. Caracteriza en este modo de fijación el uso de unas uñetas resaltadas y dispuestas equidistribuidas a lo largo del interior del cuerpo cilíndrico inferior del precinto. La configuración de estas uñetas (2) aseguran una elevada resistencia y evitan la violación del precinto dado que no ofrecen puntos de apoyo.
Patent ES-2378207-B2 (ES)
Title: Acondicionador de aire de ventilador centrífugo.
Inventor: IKEDA TAKASHI
IPC: F24F1/0022
Filed: 2008-02-19
Granted: 2013-02-15
Abstract: Acondicionador de aire de ventilador centrífugo comprende un álabe o aspa cuyo borde de aspa situado en el lado de aguas abajo según el sentido de soplado, designado como borde trasero del aspa, el ventilador presenta una relación geométrica en la que el diámetro exterior de la placa lateral es mayor que el diámetro exterior del borde trasero del aspa situado en el lado de una placa lateral, que es mayor que el diámetro exterior del borde trasero del aspa situado en el lado de una placa principal, siendo mayor o igual que el diámetro exterior de la placa principal, y el borde trasero del aspa está situado por dentro de una línea recta que une un punto de unión entre el borde trasero del aspa y la placa principal, y un punto de unión entre el borde trasero del aspa y la placa lateral, con respecto al eje de rotación del ventilador, y la distancia entre el borde trasero del aspa y el eje de rotación aumenta en dirección hacia la placa lateral desde la placa principal.
Patent ES-2613585-B2 (ES)
Title: Partículas purificadas de polen y su uso para administrar nanosistemas
Inventor: CSABA NOEMI
IPC: A61K9/50
Filed: 2017-02-09
Granted: 2018-02-19
Abstract: La presente invención se refiere a una partícula purificada de polen que conserva su capa de intina y de exina, y que comprende nanosistemas, las composiciones que la incluyen, y a sus usos.
Patent IE-S86739-B2 (IE)
Title: Method of production of a transmission unit for a fluid transfer device
Inventor: GONG ZHU
IPC: F16H1/00
Filed: 2015-09-10
Abstract: The invention relates to a design method for the transmission unit. The method includes providing the first support board of the unit at the middle portion thereof with a first belt wheel, providing the second support board at the middle portion thereof with a second belt wheel, providing the middle portion of the head end of the second support board with a third belt wheel, which interacts with the second belt wheel through the belt, arranging for the first and second belt wheels to interact with each other through the engagement between the first and second gears, arranging the head end of the fist support pillar to partly insert into the first support board, arranging the tail end of the first support pillar to partly insert into the cylinder. The transmission unit achieves that the outside power is equally distributed to the four piston units, the transmission unit can be easily mounted, it works steadily. <Figure 14>
Patent AU-2002321670-B2 (AU)
Title: Process for the production of beraprost and its salts
Inventor: SZEVERENYI ZOLTAN
IPC: C07D307/93
Filed: 2002-07-25
Granted: 2008-08-14
Abstract: The present invention relates to a new process for the preparation of beraprost of formula (I) using new intermediates. <chemistry id="CHEM-US-00001" num="000
Patent AU-2002349871-B2 (AU)
Title: Microfluidic devices with distributing inputs
Inventor: DANTSKER EUGENE
IPC: B29C65/00
Filed: 2002-06-06
Granted: 2006-10-19
Abstract: Microfluidic devices having a plurality of functional features for performing one or more fluidic operations in parallel are provided. Reagents, samples or other fluids common to multiple functional features ("common fluids") may be input into a microfluidic device or system through one or more distributing inputs that divide and distribute the common fluids as desired. The use of a multi-layer fabrication technique allows multiple distributing inputs to distribute to multiple functional features in a microfluidic device without undesirable fluid channel intersections.
Patent AU-2002367115-B2 (AU)
Title: Non-invasive device for measuring blood temperature in a circuit for the extracorporeal circulation of blood, and equipment provided with this device
Inventor: CICCO GIORGIO DE
IPC: G01K1/14
Filed: 2002-12-20
Granted: 2007-08-16
Abstract: A non-invasive device for measuring blood temperature in a circuit for the extracorporeal circulation of blood includes a line in which blood taken from a patient flows. The device also includes a temperature sensor connected to the line and provided with a device for measuring the intensity of an electromagnetic radiation. The measuring device faces a connecting portion or window of the line that is permeable by electromagnetic radiation in a first wave band, and generates a first signal, correlated with the electromagnetic radiation in the first band and therefore with the temperature of the blood flowing in the line.
Patent AU-2002367214-B2 (AU)
Title: Micro-band electrode
Inventor: WALLACE-DAVIS EMMA NAOMI KATHL
IPC: G01N27/416
Filed: 2002-12-23
Granted: 2008-08-07
Abstract: The invention concerns an electrochemical cell which, either alone or together which a substrate onto which it is placed, is in the form of a receptacle. The electrochemical cell contains a working electrode and a counter electrode, the working electrode being in a wall of the receptacle. At least one of the electrodes has at least one dimension of less than 50 μm. The electrochemical cell is principally intended for use as a micro-electrode suitable for screening water, blood, urine or other biological or non-biological fluids.
Patent AU-2002368008-B2 (AU)
Title: Table for mini-markets
Inventor: POLIDAR FRANZ
IPC: A47F10/00
Filed: 2002-07-31
Granted: 2006-01-05
Abstract: A table ( 1 ) for self-service shops includes a base frame ( 2 ) with four tubular feet ( 3 ), two side frames ( 16 ) arranged parallel and each having a first and a second wall ( 17, 18 ), and a bottom ( 22 ) arranged above the base frame ( 2 ) and surrounded by the walls ( 17, 18 ), wherein each side frame ( 16 ) is provided with two tubular uprights ( 15 ) carrying the walls ( 17, 18 ) and connected to the feet ( 3 ) of the base frame ( 2 ) by connectors so that the opposing cut surfaces ( 9 ) of the feet ( 3 ) and the uprights ( 15 ) are either arranged in a common plane ( 10 ) or are spaced apart in different planes ( 10' ).
Patent AU-2003215197-B2 (AU)
Title: Over-expression of extremozyme genes in pseudomonads and closely related bacteria
Inventor: TALBOT HENRY W
IPC: C12N9/00
Filed: 2003-02-13
Granted: 2008-06-26
Abstract: An extremoyzme over-expression system in which Pseudomonads and closely related bacteria are used as host cells, and methods and kits for use thereof, extremozymes expressed therefrom.
Patent AU-2003241107-B2 (AU)
Title: Method of isolating an endothelial cell and method of donor specific crossmatching
Inventor: SUMITRAN-HOLGERSSON SUCHITRA
IPC: A61K39/395
Filed: 2003-05-16
Granted: 2009-09-03
Abstract: The detection of endothelial cell antibodies has been proven clinically important for successful organ transplantation. Disclosed are methods of isolating Tie-2+ and CD34− precursor endothelial cells for use in donor-specific crossmatching.
Patent AU-2003293129-B2 (AU)
Title: 3-aminopyrrolidine derivatives as modulators of chemokine receptors
Inventor: ROBINSON DARIUS J
IPC: C07D401/12
Filed: 2003-11-26
Granted: 2009-03-12
Abstract: The present invention relates to 3-aminopyrrolidine derivatives of the formula I:   
(wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , X, Y and X are as defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of chemokine receptors and more specifically as a modulator of the CCR2 and/or CCR5 receptor. The compounds and compositions of the invention may bind to chemokine receptors, e.g., the CCR2 and/or CCR5 chemokine receptors, and are useful for treating diseases associated with chemokine, e.g., CCR2 and/or CCR5, activity, such as atherosclerosis, restenosis, lupus, organ transplant rejection and rheumatoid arthritis.
Patent AU-2005202198-B2 (AU)
Title: Composition for dyeing keratin fibres
Inventor: WOOD JONATHON
IPC: A61K8/49
Filed: 2005-05-20
Granted: 2010-06-17
Abstract: This invention relates to a hair dyeing composition comprising at least one anionic and at least one cationic direct acting hair dyes and showing excellent dyeing ability and excellent resistance to hair washing and environmental influences. The colouring composition of this invention are ready to use colouring composition and, therefore, do not require any mixing prior to application with additional agents such as oxidizers. According to the invention the preferred cationic dyestuffs are selected from the following structures      
and   
wherein R 1 , R 2 , R 3  and R 4  stand for hydrogen, a CH 3 - or C 2 H 5 - group, and Y is an anion such as chloride, bromide, methosulfate.